Anzeige
Mehr »
Login
Sonntag, 03.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JEQU | ISIN: CA92865M1023 | Ticker-Symbol: ABB
Tradegate
01.11.24
17:57 Uhr
0,091 Euro
+0,003
+2,84 %
Branche
Logistik/Transport
Aktienmarkt
Sonstige
1-Jahres-Chart
VOLATUS AEROSPACE INC Chart 1 Jahr
5-Tage-Chart
VOLATUS AEROSPACE INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0860,09102.11.
0,0850,09101.11.
ACCESSWIRE
421 Leser
Artikel bewerten:
(2)

Volatus Aerospace Corp.: Volatus Releases Q1 2024 Financial Results and Provides General Corporate Update

Services Revenue increases by 39% and Gross Margin increases to 34%.

TORONTO, ON / ACCESSWIRE / May 28, 2024 / Volatus Aerospace Corp. (TSXV:VOL)(OTCQB:VLTTF) ("Volatus" or "the Company"), a leader in the aerial intelligence industry, is pleased to announce its financial results for the three months ended March 31, 2024.

The Company generated revenues of $6,623,741 for the three months ended Mar 31, 2024, with a 34% gross margin, and adjusted EBITDA improvement of $378,215 between Q1 2023 and Q1 2024.

Q1 2024 Performance Highlights:

  • Service Revenue increased by 39% from $2.78M in Q1 2023 to $3.9M.
  • Gross profit was $2,225,757. In Q1 2024, the Company successfully increased its gross margin percentage from 32% in Q1 2023 to 34%. This growth in the gross margin is a direct result of our strategic shift towards higher efficiency operations and an optimized product mix. Notably, the significant increase in our aerial intelligence service activities has been a key driver of this improvement.
  • Available cash on hand on December 31, 2023, was $1,040,925, and as part of a subsequent event, the Company raised additional $950,000 on May 21, 2024. The temporary limitation in growth working capital led to a decline in equipment revenue by 40% in the current quarter.
  • The Comprehensive loss of ($2,991,319) in Q1 2024 compared to ($3,003,365) Q1 2023. The increase in loss is due to higher depreciation expenses and interest charges.
  • Adjusted EBITDA improved by 22% to ($1,380,119) from ($1,785,335) in Q1 2023. Efficiency measures implemented in late Q3 2023 will continue to be realised over the next few quarters. Management feels that adjusted EBITDA is an efficient measure of the performance of the Company.

Notable Operational Accomplishments During the Quarter:

  • Continued expansion in the UK with the strategic acquisition of UAV Hub and Drone Mentor.
  • Continued expansion in oil and gas sector in the U.S. by leveraging advanced technological applications such as optical gas inspections and magnetometry
  • Secured work for the inspection of 11,000 structures in the US utility sector.
  • Expanded LiDAR services in Eastern Canada and secured work in the growing façade and building envelope inspections sector in the U.S.

Webinar

In conjunction with this release, Volatus investor relations will host a webinar on Thursday, May 30 th at 8:30 AM EST at which time Glen Lynch, Chief Executive Officer, and Abhinav Singhvi, Chief Financial Officer, will review financial results and major milestones with Danielle Gagne, Head of Corporate Communications as moderator. Investors are invited to register for the webinar here .

https://us06web.zoom.us/webinar/register/WN_toHGFuw3S7etj0PEFajy9Q

Audio Replay Options

An audio replay of the event will be archived on the Investor Relations page of the company's website here .

SUMMARY OF RESULTS

Three months
ended March 31
2024 2023
Revenue
$6,623,741 $7,412,480
Direct costs
$4,397,985 5,045,802
Gross Profit
2,225,757 2,366,678
OPERATING EXPENSES
Advertising & marketing
$293,339 406,118
IT & tech
$256,802 185,095
Personnel
$2,196,722 2,156,297
R&D
$11,840 100,420
Office cost
$583,199 892,539
Travel
$57,621 94,285
External partner cost
$200,072 274,013
Depreciation and amortization
$1,098,088 745,136
Share based Payments
$126,822 176,401
4,824,504 5,030,304
(Loss) from Operations
(2,598,748) (2,663,626)
OTHER ITEMS - INCOME/(EXPENSE)
Finance cost
$(379,106) (312,982)
Other income (expense)
$(10,168) (1,558)
Gain (Loss) on disposal of property and equipment
$(7,184) (10,511)
Foreign exchange translation
$3,887 (14,688)
Net Loss
$(2,991,319) $(3,003,365)
Total comprehensive Income (loss) for the period attributable to:
Owners of Volatus Aerospace Corp.
(2,915,143) (2,611,890)
Non-controlling interest
(76,176) (391,475)
(2,991,319) (3,003,365)

SUMMARY OF QUARTERLY RESULTS


Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022
Revenue
6,623,741 10,500,995 8,274,349 8,684,991 7,412,480 7,213,129 11,120,589 6,629,593

Direct Cost
4,397,985 7,700,881 5,265,775 5,724,516 5,045,802 5,190,979 7791145 4728672.918
Gross Profit
2,225,757 2,800,114 3,008,574 2,960,475 2,366,678 2,022,150 3,329,444 1,900,920
33.60% 26.67% 36.36% 34.09% 31.93% 28.03% 29.94% 28.67%
OPERATING EXPENSES
Advertising & marketing
293,339 278,781 541,635 629,686 406,118 575,539 599,285 591,365
IT & tech
256,802 28,439 243,602 211,960 185,095 164,260 140,392 110,775
Personnel
2,196,722 1,312,983 1,727,086 1,788,347 2,156,297 1,552,913 1,393,606 1,565,456
R&D
11,840 771,861 104,832 364,263 100,420 541,023 - -
Office cost
583,199 605,396 722,276 610,650 892,539 490,740 378,474 416,589
Travel
57,621 126,710 90,804 167,364 94,285 144,372 140,622 54,456
External partner cost
200,072 436,686 243,443 326,979 274,013 602,171 403,238 168,371
Depreciation
1,098,088 1,647,364 843,744 797,487 745,136 604,849 270,081 300,511
Share based Payments
126,822 173,671 195,372 178,361 176,401 340,761 330,918 290,103
4,824,504 5,381,891 4,712,793 5,075,097 5,030,304 5,016,628 3,656,616 3,497,626
(Loss) from Operations
2,598,748 (2,581,777) (1,704,219) (2,114,622) (2,663,626) (2,994,477) (327,172) (1,596,707)
OTHER ITEMS - INCOME/(EXPENSE)
-
Finance cost
379,106 (667,949) (425,671) (368,635) (312,982) (249,798) (121,672) (81,239)
Bargain Purchase Gain
221,808 2,112,197 - -
Changes in Fair Value of Contingent Consideration
386,731 (33,846) - -
Other income (expense)
(10,168) 14,955 (39,229) 41,237 (1,558) 192,498 79,640 31,576
Gain (Loss) on disposal of equipment
(7,184) (125,476) 228,769 (0) (10,511) 414 10,566 (1,011)
Foreign exchange translation
3,887 (24,156) 19,946 (16,191) (14,688) (195,277) 6,430 20,484
Net loss and comprehensive loss before tax
(2,991,319) (2,775,864) (1,920,403) (2,458,211) (3,003,365) (1,168,290) (352,208) (1,626,897)
Deferred Tax Income/ (Expense)
464,216 (71,311)
Net Loss and comprehensive loss after tax
(2,991,319) (2,311,647) (1,920,403) (2,458,211) (3,003,365) (1,239,601) (352,208) (1,626,897)
Loss per share
Basic and Diluted
(0.02) (0.02) (0.02) (0.03) (0.02) (0.01) (0.01) (0.02)

RECONCILIATION OF ADJUSTED EBIDTA TO NET LOSS

Three months
ended Mar 31,
2024 2023
Adjusted EBITDA (loss)
(1,380,119) (1,758,335)
Interest
379,106 312,982
Depreciation
1,098,088 745,136
Share-based Payments
126,822 176,401
Loss from Sale of Drones
7,184 10,511
Net Loss
(2,991,319) (3,003,365)

Other Corporate Update:

Further to the Company's press release dated May 21, 2024, we are pleased to announce completion of first tranche of previously announced non-brokered private placement of up to 1,000, $1,000 principal amount unsecured non-convertible debentures (the "Debentures") for gross proceeds of $585,060 through the issuance of 597 Debentures at a price of $980 per debenture (the "Offering").

The Debentures shall have a maturity date of 12 months from the date of issuance and will bear an initial interest rate of 15.0% per annum if the Debentures remain outstanding for 7 months or less. If the Debentures remain outstanding longer than 7 months, beginning with month 8, the annualized initial interest rate shall increase by 1.0% each month until maturity, at which point the maximum annualized interest rate will be 20.0%. The Debentures are redeemable, in whole or in part, at any time, at the option of Volatus. If, at any time while the Debentures remain outstanding and prior to the maturity date of the Debentures, Volatus completes a financing of equity or quasi-equity securities of Volatus with a minimum of ten distinct investors, holders of Debentures will be entitled to participate in such financing up to the amount of principal of their respective Debentures at a price per security equal to the greater of (i) a 10% discount to such financing price and (ii) the maximum discount to such financing price permitted by the policies of the TSX Venture Exchange (" TSXV "). It is anticipated that the net proceeds of the Offering will be used for the purchase of inventory, sales and marketing, and working capital requirements of Volatus. As disclosed in the Company's press release dated May 21, 2024, the Company may proceed with a subsequent tranche, and the Merger is not contingent on the closing of any subsequent tranches.

In connection with the Offering, the Company paid eligible Finders a cash commission equal to $51,500.00. All securities issued pursuant to the Offering are subject to a statutory four month plus a day hold period from their date of issuance.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act ") or any applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. "United States" and "U.S. persons" shall have the meanings assigned to them in Regulation S under the U.S. Securities Act.

About Volatus Aerospace:

Volatus Aerospace Corp. is a leading international provider of aerial intelligence solutions, using drones and commercial aircraft. Volatus serves civil, public safety, and defense markets with imaging and inspection, security and surveillance, equipment sales and support, training, as well as R&D, design, and manufacturing. We are focused on introducing green and innovative drone solutions to supplement and replace traditional aircraft and helicopters for long-linear inspections such as pipeline, energy, rail, and cargo services. Volatus is committed to carbon neutrality; the fostering of a safe, equitable and inclusive workplace; and responsible governance.

Note Regarding Non-GAAP Measures

In this press release we describe certain income and expense items that are unusual or non-recurring. There are terms not defined by International Financial Reporting Standards (IFRS). Our usage of these terms may vary from the usage adopted by other companies. Specifically, gross profit, gross margin, and Adjusted EBITDA are undefined terms by IFRS that may be referenced herein. We provide this detail so that readers have a better understanding of the significant events and transactions that have had an impact on our results.

Throughout this release, reference is made to "gross profit," "gross margin," and "Adjusted EBITDA" which are non-IFRS measures. Management believes that gross profit, defined as revenue less operating expenses, is a useful supplemental measure of operations. Gross profit helps provide an understanding on the level of costs needed to create revenue. Gross margin illustrates the gross profit as a percentage of revenue. Adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"). The Company defines Adjusted EBITDA as IFRS comprehensive loss excluding interest expense, depreciation and amortization expense, share-based payments, income tax expense, integration and due diligence costs, one time profit or loss (non-recurring), and impairment of goodwill, property, plant, and equipment and right-of-use assets (ROU). The Company believes that Adjusted EBITDA is a meaningful financial metric as it measures cash generated from operations which the Company can use to fund working capital requirements, service future interest and principal debt repayments and fund future growth initiatives. Readers are cautioned that these non-IFRS measures may not be comparable to similar measures used by other companies. Readers are also cautioned not to view these non-IFRS financial measures as an alternative to financial measures calculated in accordance with International Financial Reporting Standards ("IFRS"). Adjusted EBITDA does not have any standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers and should not be construed as alternatives to comprehensive loss or income determined in accordance with IFRS. For more information with respect to financial measures which have not been defined by GAAP, including reconciliations to the closest comparable GAAP measure, see the "Non-GAAP Measures and Additional GAAP Measures"? section of the Company's most recent MD&A which is available on SEDAR.

Forward-Looking Statement

This news release contains statements that constitute "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs, and current expectations of the Company with respect to future business activities and operating performance. Often, but not always, forward-looking information and forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results "may", "could", "would", "might" or "will" (or other variations of the foregoing) be taken, occur, be achieved, or come to pass. Forward-looking information includes information regarding: (i) the business plans and expectations of the Company; and (ii) expectations for other economic, business, and/or competitive factors. Forward-looking information is based on currently available competitive, financial, and economic data and operating plans, strategies, or beliefs as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors may be based on information currently available to the Company, including information obtained from third-party industry analysts and other third-party sources, and are based on management's current expectations or beliefs. Any and all forward-looking information contained in this news release is expressly qualified by this cautionary statement. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Forward-looking information and forward-looking statements reflect the Company's current beliefs and is based on information currently available to it and on assumptions it believes to be not unreasonable in light of all of the circumstances. In some instances, material factors or assumptions are discussed in this news release in connection with statements containing forward-looking information. Such material factors and assumptions include, but are not limited to: the commercialization of drone flights beyond visual line of sight and potential benefits to the Company; and meeting the continued listing requirements of the TSXV. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. The forward-looking information contained herein is made as of the date of this news release and, other than as required by law, the Company disclaims any obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

TSXV: VOL
OTCQB: VLTTF

CONTACT DETAILS
Abhinav Singhvi
Chief Financial officer
+1 833-865-2887
abhinav.singhvi@volatusaerospace.com

COMPANY WEBSITE
https://volatusaerospace.com

SOURCE: Volatus Aerospace Corp.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.